Fig. 2
From: Expression patterns of immune checkpoints in acute myeloid leukemia
Co-expression patterns of ICs related to poor OS in AML patients. a, b Comparison of OS curves in AML patients with PD-1high, PD-L1high, or PD-L2high co-expressed with CTLA-4low or CTLA-4high in TCGA group (a) and the validation group (n = 62) (b), respectively. c Comparison of OS curves in AML patients with or without FLT3, RUNX1, or TET2 mutation in TCGA group. mut mutation, wt wildtype. d Schematic summary of optimal IC combination detection for OS analysis in AML patients with genetic mutations